​

Drugs Made In America Acquisition II Ownership | Who Owns Drugs Made In America Acquisition II?


OverviewFinancialsChart

Drugs Made In America Acquisition II Ownership Summary


Drugs Made In America Acquisition II is owned by 94.54% institutional investors, 15.27% insiders. Glazer capital is the largest institutional shareholder, holding 17.68% of DMII shares. Karpus Tax Sensitive Fixed Income is the top mutual fund, with 1.80% of its assets in Drugs Made In America Acquisition II shares.

DMII Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDrugs Made In America Acquisition II94.54%15.27%-9.81%
SectorFinancial Services Stocks 163.44%13.86%-77.30%
IndustryFinancial Conglomerates Stocks64.09%15.91%20.00%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Glazer capital2.35M17.68%$23.43M
Millennium management1.98M14.87%$19.70M
Tenor capital management1.50M11.29%$14.96M
Polar asset management partners1.50M11.29%$14.96M
D. e. shaw1.39M10.46%$13.87M
Hgc investment management1.23M9.26%$12.27M
Aqr arbitrage1.11M8.37%$11.10M
Aristeia capital1.10M8.28%$10.97M
Davidson kempner capital management lp1.00M7.53%$9.98M
Two sigma investments, lp886.54K6.67%$8.84M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mercuria capital strategies750.00K4.37%$7.63M
Hgc investment management1.23M2.72%$12.27M
Kepos capital lp210.00K2.66%$2.14M
Crossingbridge advisors1.10M1.96%$11.20M
Mmcap inc. spc2.70M1.81%$27.49M
Heights capital management519.40K1.44%$5.18M
Karpus management3.30M1.01%$33.59M
Wealthspring capital399.15K0.91%$4.06M
First trust capital management1.30M0.64%$13.22M
Glazer capital2.35M0.50%$23.43M

Top Buyers

HolderShares% AssetsChange
Heights capital management519.40K1.44%519.40K
Karpus management3.30M1.01%512.02K
Millennium management1.98M0.01%476.43K
D. e. shaw1.39M0.01%390.10K
Rivernorth capital management300.00K0.15%300.00K

Top Sellers

HolderShares% AssetsChange
Healthcare of ontario pension plan trust fund---2.00M
Sculptor capital lp---500.00K
Jpmorgan chase129.63K0.00%-426.32K
Commonwealth of pennsylvania public school empls retrmt sys---350.00K
Clear street group15.35K0.00%-166.18K

New Positions

HolderShares% AssetsChangeValue
Heights capital management519.40K1.44%519.40K$5.18M
Rivernorth capital management300.00K0.15%300.00K$2.99M
Highbridge capital management225.00K0.07%225.00K$2.25M
Schonfeld strategic advisors112.32K0.01%112.32K$1.12M
Penderfund capital management49.70K0.08%49.70K$496.01K

Sold Out

HolderChange
Morgan stanley-63.00
Mizuho securities usa-18.60K
Cable car capital-100.00K
Dld asset management, lp-100.00K
Quarry lp-100.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202664-8.57%47,271,6473.94%941.14%14-33.33%14-
Jun 30, 2026691.47%45,229,6912.96%901.17%20-33.33%14-6.67%
Mar 31, 202619-62.75%11,482,051-66.93%860.01%6-88.24%6-
Dec 31, 202551-34,724,554-1,277-51---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Karpus Tax Sensitive Fixed Income1.14M1.80%837.87K
CrossingBridge Low Dur Hi Inc Instl1.07M1.69%-
First Trust Merger Arbitrage Cl I913.21K1.43%-
PICTON Arbitrage Plus Alternative Fund F685.19K1.08%-
Karpus Conservative Balanced588.70K0.92%449.52K
The Merger Fund A515.37K0.81%103.61K
Karpus Taxable Fixed Income479.40K0.75%206.28K
Westchester Merger Arbitrage Composite411.75K0.65%-
Karpus Growth Balanced296.65K0.47%153.57K
GAMCO Intl SICAV Merger Arbtrg I (USD)128.84K0.20%-27.76K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2025Stockwell Lynn CEO and Exe. Chair of BoardBuy-
Sep 26, 2025Stockwell Lynn CEO and Exe. Chair of BoardSell$11.95M
Sep 26, 2025Stockwell Lynn CEO and Exe. Chair of BoardBuy-
Sep 26, 2025Drugs Made In America Acquisition II LLC-Buy-
Sep 26, 2025Drugs Made In America Acquisition II LLC-Sell$11.95M

DMII Ownership FAQ


Who Owns Drugs Made In America Acquisition II?

Drugs Made In America Acquisition II shareholders are primarily institutional investors at 94.54%, followed by 15.27% insiders and -9.81% retail investors. The average institutional ownership in Drugs Made In America Acquisition II's industry, Financial Conglomerates Stocks, is 64.09%, which Drugs Made In America Acquisition II exceeds.

Who owns the most shares of Drugs Made In America Acquisition II?

Drugs Made In America Acquisition II’s largest shareholders are Glazer capital (2.35M shares, 17.68%), Millennium management (1.98M shares, 14.87%), and Tenor capital management (1.5M shares, 11.29%). Together, they hold 43.85% of Drugs Made In America Acquisition II’s total shares outstanding.

Does Blackrock own Drugs Made In America Acquisition II?

BlackRock is not among the top 10 institutional shareholders of Drugs Made In America Acquisition II.

Who is Drugs Made In America Acquisition II’s biggest shareholder by percentage of total assets invested?

Mercuria capital strategies is Drugs Made In America Acquisition II’s biggest shareholder by percentage of total assets invested, with 4.37% of its assets in 750K Drugs Made In America Acquisition II shares, valued at 7.64M$.

Who is the top mutual fund holder of Drugs Made In America Acquisition II shares?

Karpus Tax Sensitive Fixed Income is the top mutual fund holder of Drugs Made In America Acquisition II shares, with 1.80% of its total shares outstanding invested in 1.14M Drugs Made In America Acquisition II shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools